Indications for and use of antidepressants in child and adolescent psychiatry: A cross-sectional survey in Denmark

European Child and Adolescent Psychiatry

Volumn 12, Issue 3, 2003, Pages 114-121

  Buhl Sørensen, Christine ^a   Jepsen, Ea Bøhm ^a   Thomsen, Per Hove ^a   Dalsgaard, Søren ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Adolescents; Antidepressants; Children; Nationwide cross sectional survey

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CITALOPRAM; FLUOXETINE; FLUVOXAMINE; HYPNOTIC SEDATIVE AGENT; LITHIUM CARBONATE; MIANSERIN; MIRTAZAPINE; MOCLOBEMIDE; NEFAZODONE; NEUROLEPTIC AGENT; NORTRIPTYLINE; PAROXETINE; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADOLESCENCE; ADOLESCENT; AGITATION; ANXIETY DISORDER; CHILD; CHILD PSYCHIATRY; DENMARK; DEPRESSION; DRUG INDICATION; EATING DISORDER; GILLES DE LA TOURETTE SYNDROME; HEADACHE; HEALTH SURVEY; HUMAN; HYPERKINESIA; MENTAL HOSPITAL; NAUSEA; OBSESSIVE COMPULSIVE DISORDER; OUTPATIENT CARE; OUTPATIENT DEPARTMENT; PRESCRIPTION; PSYCHOPHARMACOTHERAPY; PUBLIC HEALTH SERVICE; QUESTIONNAIRE; REVIEW; SLEEP DISORDER; TREATMENT INDICATION;

ADOLESCENT; ADOLESCENT PSYCHIATRY; ADULT; ANTIDEPRESSIVE AGENTS; CHILD; CHILD PSYCHIATRY; CROSS-SECTIONAL STUDIES; DENMARK; DEPRESSIVE DISORDER; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; PRESCRIPTIONS, DRUG;

EID: 0038613563     PISSN: 10188827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00787-003-0316-4     Document Type: Review

References (21)

1. Alderman J, Wolkow R, Chung M, Johnston H (1998) Sertralin treatment of children and adolescents with obsessive-compulsive disorder or depression. Journal of the American Academy of Child and Adolescent Psychiatry 37:386-394
2. Birmaher B, Waterman GS, Ryan N (1994) Fluoxetine for childhood anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry 33:993-999
3. Black B, Uhde TW (1994) Fluoxetine treatment of elective mutism; A double blind placebo-controlled study. Journal of the American Academy of Child and Adolescent Psychiatry 33:1000-1006
4. Bramble DJ (1995) Antidepressant prescription by British child psychiatrists: practice and safety issues. Journal of the American Academy of Child and Adolescent Psychiatry 34:327-331
5. Cook EH, Rowlett R, Jaselskis C, Leventhal BL (1992) Fluoxetine treatment of children and adults with autistic disorder and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry 31:739-745
6. DeVane CL, Sallee FR (1996) Serotonin selective reuptake inhibitors in child and adolescent psychopharmacology; a review of published experience. Journal of Clinical Psychiatry 57:55-66
7. Donoghue J, Tylee A, Wildgust H (1996) Cross sectional database analysis of antidepressant prescribing in general practice in the United Kingdom, 1993-95. British Medical Journal 313:861-862
8. Emslie GJ, Rush J, Weinberg WA, Kowath RA, Hughes CW, Carmody T, Rintelmann J (1997) A double-blind randomized, placebo controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry 54:1031-1037
9. Halen TR, Crown WH, Meneades L, Heiligenstein JH, Melfi C, Croghan TW, Buesching DP (1999) SSRI antidepressant drug use patterns in the naturalistic setting. Medical Care 37:36-44
10. Kaye WH, Weltzin TE, Hsu LKG, Bulik M, McConaha C (1991) An open trial of fluoxetine in patients with anorexia nervosa. Journal of Clinical Psychiatry 52:464-471
11. Kurlan R, Como PG, Deley C (1993) A pilot controlled study of fluoxetine for obsessive-compulsive symptoms in children with Tourette's syndrome. Clinical Neuropharmacology 16:167-172
12. Lawrenson RA, Tyrer F, Newson RB, Farmer RD (2000) The treatment of depression in UK general practice: selective serotonin re-uptake inhibitors and tricyclic antidepressants compared. Journal of Affective Disorders 59:149-157
13. Leonard HL, March J, Kenneth MPH, Rickler C, Allen AJ (1997) Pharmacology of the selective serotonin re-uptake inhibitors in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 36:725-736
14. Munk-Jørgensen P, Kastrup M, Mortensen PB (1993) The Danish Psychiatric Register as a tool in epidemiology. Acta Psychiatrica Scandinavica 87:27-32
15. Nie NH, Hull CH, Jenkins JG, Steinbrenner K, Bent DH (1975). SPSS: Statistical Package for the Social Sciences. New York
16. Riddle MA, Hardin MT, Scahill L, King RA, Woolston JL (1990) Doubleblind trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder: preliminary clinical experience. Journal of the American Academy of Child and Adolescent Psychiatry 29:45-48
17. Sørensen L (1998) Børns og unges forbrug af psykofarmaka, psykostimulantia og antidepressiva. Ugeskrift for Læger 160:7433-7437
18. Thomsen PH (1997) Child and adolescent obsessive-compulsive disorder treated with citalopram: findings from an open trial of 23 cases. Journal of Child and Adolescent Psychopharmacology 7:157-166
19. Thomsen PH (1998) Indikationer for brug af serotoninspecifikke genoptagelseshæmmere hos børn og unge. Ugeskrift for Læger 160:7285-7290
20. Walkup JT, Labellarte MJ, Riddle MA, Pine DS, Greenhill L, Klein R, Davies M, Sweeney M, Abikoff H, Hack S, Klee B, McCracken J, Bergman L, Piacentini J, March J, Compton S, Robinson J, O'Hara T, Baker S, Vitiello B, Ritz L, Roper M (2001) Fluvoxamine for the treatment of anxiety disorders in children and adolescents. New England Journal of Medicine 344:1279-1285
21. Zito JM, Safer DJ, dosReis S, Gardner JF, Boles M, Lynch F (2000) Trends in the prescribing of psychotropic medications to preschoolers. Journal of the American Medical Association 283:1025-1030